Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Frost & Sullivan honors Teladoc with Product Line Strategy Leadership Award for Virtual Telemedicine Services

TDOC

Teladoc, Inc. (NYSE: TDOC), the nation’s first and largest telehealth provider, announced the company has been honored with Frost & Sullivan's 2016 Product Line Strategy Leadership Award for Virtual Telemedicine Services.

“We are honored that Frost & Sullivan has recognized Teladoc's leadership in virtual health and the quality and strength of our innovative product line and customer impact,” said Jason Gorevic, Teladoc chief executive officer. “Frost & Sullivan’s findings that Teladoc has showcased best practices in its product mix and strategy aimed at achieving national scale is an honor we take seriously.”

"Teladoc stands alone in the virtual telemedicine segment as building true national scale and also as the pioneer in breaking down barriers to implementing quality telehealth," said Victor Camlek, principal analyst for Telehealth of Frost & Sullivan. “While many companies are operating within the telehealth space, Teladoc has demonstrated a national scale and multi-faceted product strategy based on a strong business model that has been marked by introducing products aimed at addressing various identified healthcare consumer needs. Because of its strong overall performance, Teladoc has earned Frost & Sullivan’s 2016 Product Line Strategy Award.”

According to analysis from Frost & Sullivan (details available at http://ww2.frost.com/files/5714/6101/5545/Teledoc_Award_Write_Up.pdf), Teladoc scored a perfect 10 out of 10 points in Frost & Sullivan's customized Decision Support Scorecard, besting its nearest competitors in product line strength criteria including breadth, scalability, technology leverage, and features, and customer impact criteria such as price/performance value, customer experience, and brand equity.

The Frost & Sullivan analysis points out that Teladoc is the most widely used service of its kind, offering broader national presence than its competitors, and has strong name recognition. In contrast, competitors have been hampered by the lack of a national presence, the goal to offer too high a percentage of costly video services, or limited range of coverage.

The analysis from Frost & Sullivan also notes that Teladoc has developed a well-defined price/performance scenario, with measureable ROI and a strong customer engagement capability.

About Teladoc
Teladoc, Inc. (NYSE: TDOC) is the nation’s first and largest telehealth platform, delivering on-demand health care anytime, from almost anywhere via mobile devices, the Internet, secure video and phone. Teladoc provides consumers with access to its network of more than 3,100 board-certified, state-licensed physicians and behavioral health professionals who provide care for a wide range of non-emergency conditions. With a median response time of less than 10 minutes, Teladoc physicians performed more than 575,000 telehealth visits in 2015. Teladoc and its physicians consistently earn a 95 percent member satisfaction rating or better, and Teladoc is the first telehealth provider to be certified by the National Committee for Quality Assurance (NCQA) for its physician credentialing process.

Recognized in June 2015 by MIT Technology Review as one of the “50 Smartest Companies,” Teladoc works with health plans, employers, organizations and individuals to provide access to affordable, high-quality health care on-demand. Teladoc is transforming the access, cost and quality dynamics of health care delivery. For more information, please visit teladoc.com, twitter.com/teladoc, facebook.com/teladoc or linkedin.com/teladoc.

About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants.

Our “Growth Partnership” supports clients by addressing these opportunities and incorporating two key elements driving visionary innovation: The Integrated Value Proposition and The Partnership Infrastructure.

  • The Integrated Value Proposition provides support to our clients throughout all phases of their journey to visionary innovation including: research, analysis, strategy, vision, innovation and implementation.
  • The Partnership Infrastructure is entirely unique as it constructs the foundation upon which visionary innovation becomes possible. This includes our 360 degree research, comprehensive industry coverage, career best practices as well as our global footprint of more than 40 offices.

For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organization prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies?

Teladoc, Inc.
Patty Sullivan, 469-294-5096
pr@teladoc.com



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today